Stock comparison
Medline Inc. is 20.9x more valuable than LEMAITRE VASCULAR INC by market capitalization ($49.12 B vs $2.35 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MDLN is larger
Medline Inc. is 20.9x more valuable than LEMAITRE VASCULAR INC by market capitalization ($49.12 B vs $2.35 B).
Market value leader
MDLN
Medline Inc. is 20.9x more valuable than LEMAITRE VASCULAR INC by market capitalization ($49.12 B vs $2.35 B).
Revenue leader
MDLN
LMAT: $249.60M vs MDLN: $28.43B.
Profit leader
MDLN
LMAT: $57.70M vs MDLN: $1.16T.
Margin leader
MDLN
LMAT: 23.1% vs MDLN: 4069.4% net margin.
| Metric | LMAT | MDLN |
|---|---|---|
| Market cap | $2.35 B | $49.12 B |
| US-listed rank | #2018 | #330 |
| Revenue (latest FY) | $249.60M | $28.43B |
| Net income (latest FY) | $57.70M | $1.16T |
| Net margin | 23.1% | 4069.4% |
| P/E (trailing FY) | 40.7x | 0.0x |
| SEC filings | 1,849 | 103 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Medline Inc. is 20.9x more valuable than LEMAITRE VASCULAR INC by market capitalization ($49.12 B vs $2.35 B).
In their latest fiscal years, LEMAITRE VASCULAR INC reported $249.60M in revenue while Medline Inc. reported $28.43B.
Full pages: LEMAITRE VASCULAR INC and Medline Inc., or browse the full rankings.